GlassScriptPhysician profile
Betsy V Rajan
NPI 1326695917
$1,731.91
in general payments reported to CMS, 2019-2025
16 companies · $18.08 in 2025
The $18.08 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $407 · 2022: $773 · 2023: $364 · 2024: $170 · 2025: $18.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,001.59 | 2021-2025 | |
| Myovant Sciences INC. | $131.14 | 2022 | |
| Pfizer INC. | $118.98 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $73.55 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $71.52 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $60.38 | 2021-2022 | |
| Astellas Pharma US INC | $43.73 | 2021-2022 | |
| Novo Nordisk INC | $36.50 | 2022-2023 | |
| Mylan Pharmaceuticals INC. | $33.21 | 2021 | |
| Agile Therapeutics, INC. | $27.98 | 2021-2022 | |
| Hologic Sales and Service, LLC | $27.38 | 2023 | Aptima |
| Avion Pharmaceuticals | $25.87 | 2021 | |
| Merck Sharp & Dohme LLC | $25.03 | 2023 | Gardasil 9 |
| Ethicon US, LLC | $21.62 | 2022 | |
| Seqirus USA INC | $19.33 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Rajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.